Clinical trial
A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis
NCT00242268 is registered in ClinicalTrials.gov with Alabama Neurology Associates, PC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis
- Lead sponsor
- Alabama Neurology Associates, PC
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- October 31, 2005
- Completion date
- Not reported
- Enrollment
- 30
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
relapsing remitting multiple sclerosis